• Info
  • Significant Ownership

Significant Ownership of BML Investment Partners, L.P.

Signature - Title
Braden M Leonard - BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member
Location
Zionsville, IN
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BML Investment Partners, L.P..

Notify me when BML Investment Partners, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of BML Investment Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ACRS Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value 12% $37,620,000 14,250,000 0% BML Investment Partners, L.P. 31 Dec 2025
OM Outset Medical, Inc. Common Stock, par value $0.001 per share 10% $9,739,269 +$1,005,184 1,902,201 +12% BML Investment Partners, L.P. 12 Feb 2026
ACHL Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share 10% $6,066,773 4,100,002 BML Investment Partners, L.P. 31 Dec 2024
AVIR Atea Pharmaceuticals, Inc. Common Stock 9.9% $27,881,700 +$2,119,466 7,810,000 +8.2% Leonard Braden Michael 31 Dec 2025
PMVP PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share 9.9% $6,615,000 +$2,527,616 5,292,000 +62% BML Investment Partners, L.P. 31 Dec 2025
KZR Kezar Life Sciences, Inc. Common Stock, $0.001 par value 9.8% 720,787 +96% BML Investment Partners, L.P. 31 Dec 2025
EPIX ESSA Pharma Inc. Common Shares 9.5% $7,598,783 +$68,981 4,221,546 +0.92% BML Investment Partners, L.P. 24 Apr 2025
TIL Instil Bio, Inc. Common Stock, $0.000001 par value per share 9.5% +$2,261,600 645,600 +47% BML Investment Partners, L.P. 31 Dec 2025
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.5% $4,335,508 +$470,890 4,090,102 +12% Leonard Braden Michael 16 Jun 2025
ORMP ORAMED PHARMACEUTICALS INC. Common Stock par value $0.012 per share 8.3% $11,276,231 +$2,207,630 3,287,531 +24% Leonard Braden Michael 31 Dec 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 8.2% $19,179,460 3,724,167 BML Investment Partners, L.P. 11 Feb 2025
LVTX LAVA Therapeutics N.V. Common shares, par value $0.14 per share 7.4% $2,702,192 1,958,110 BML Investment Partners, L.P. 26 Feb 2025
WHWK Aadi Bioscience, Inc. Common stock, par value $0.0001 per share 5% $3,749,900 -$331,178 2,435,000 0% Leonard Braden Michael 05 Mar 2025
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 1.9% 220,832 Leonard Braden Michael 25 Jul 2025
ANTX AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share 1.4% $551,387 -$3,599,088 427,432 -87% BML Investment Partners, L.P. 17 Jun 2025
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BML Investment Partners, L.P. 31 Dec 2024
ELEV Elevation Oncology, Inc. Common stock, par value $0.0001 per share 0% $0 -$2,162,562 0 -100% BML Investment Partners, L.P. 23 Jul 2025
TECX Tectonic Therapeutic, Inc. Common Stock, $0.0001 par value per share 0% $0 0 BML Investment Partners, L.P. 31 Dec 2024
ASTC Astrotech Corporation Common Stock, $0.001 par value per share 0% $0 0 BML Investment Partners, L.P. 03 Oct 2025
ATHA Athira Pharma Inc. Common Stock, $0.0001 par value 0% $0 -$5,608,138 0 -100% BML Investment Partners, L.P. 18 Dec 2025
ADVM Adverum Biotechnologies, Inc. Common Stock, par value $0.0001 per share 0% -$9,738,956 0 -100% BML Investment Partners, L.P. 09 Dec 2025

Schedules 13D/G Reported by BML Investment Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.